21/09/2026
A country can have the best laboratories in the world and still lose the strategic game.
That is the core warning in our new report “The Pharma Urgency for Belgium and Europe: Frontrunner or Decline?” by Anton Delbarre and Marc De Vos.
Europe’s problem is not capability but conversion: turning strong science into patient access, clinical evidence, production depth and anchored investment. Five insights from the roundtable: head to itinera.team